Cargando…

Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges

In children and adolescents with conduct disorder (CD), pharmacotherapy is considered when non-pharmacological interventions do not improve symptoms and functional impairment. Risperidone, a second-generation antipsychotic is increasingly prescribed off-label in this indication, but its efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glennon, Jeffrey, Purper-Ouakil, Diane, Bakker, Mireille, Zuddas, Alessandro, Hoekstra, Pieter, Schulze, Ulrike, Castro-Fornieles, Josefina, Santosh, Paramala J., Arango, Celso, Kölch, Michael, Coghill, David, Flamarique, Itziar, Penzol, Maria J., Wan, Mandy, Murray, Macey, Wong, Ian C. K., Danckaerts, Marina, Bonnot, Olivier, Falissard, Bruno, Masi, Gabriele, Fegert, Jörg M., Vicari, Stefano, Carucci, Sara, Dittmann, Ralf W., Buitelaar, Jan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2013
Materias:	Original Contribution
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246122/ https://www.ncbi.nlm.nih.gov/pubmed/24337449 http://dx.doi.org/10.1007/s00787-013-0498-3

Ejemplares similares

Psychosocial risk factors for suicidality in children and adolescents
por: Carballo, J. J., et al.
Publicado: (2019)

Development and psychometric properties of the Suicidality: Treatment Occurring in Paediatrics (STOP) Suicidality Assessment Scale (STOP-SAS) in children and adolescents
por: Flamarique, I., et al.
Publicado: (2016)

Development and psychometric properties of the “Suicidality: Treatment Occurring in Paediatrics (STOP) Risk and Resilience Factors Scales” in adolescents
por: Rodríguez-Quiroga, A., et al.
Publicado: (2019)

Erratum to: Eunethydis: a statement of the ethical principles governing the relationship between the European group for ADHD guidelines, and its members, with commercial for-profit organisations
por: Sergeant, Joseph A., et al.
Publicado: (2010)

The quality of life of children with attention deficit/hyperactivity disorder: a systematic review
por: Danckaerts, Marina, et al.
Publicado: (2009)

Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale
por: Kovshoff, Hanna, et al.
Publicado: (2016)

Emotion recognition profiles in clusters of youth based on levels of callous-unemotional traits and reactive and proactive aggression
por: Kleine Deters, Renee, et al.
Publicado: (2022)

Neuropsychological Characterization of Aggressive Behavior in Children and Adolescents with CD/ODD and Effects of Single Doses of Medications: The Protocol of the Matrics_WP6-1 Study
por: Balia, Carla, et al.
Publicado: (2021)

Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine
por: Hennissen, Leonie, et al.
Publicado: (2017)

Eunethydis: a statement of the ethical principles governing the relationship between the European group for ADHD guidelines, and its members, with commercial for-profit organisations
por: Sergeant, Joseph A., et al.
Publicado: (2010)

Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study
por: Inglis, S K, et al.
Publicado: (2016)

The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)
por: Coghill, David, et al.
Publicado: (2021)

Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)
por: McCarthy, Suzanne, et al.
Publicado: (2018)

ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group
por: Cortese, Samuele, et al.
Publicado: (2020)

Remote assessment of ADHD in children and adolescents: recommendations from the European ADHD Guidelines Group following the clinical experience during the COVID-19 pandemic
por: Santosh, P., et al.
Publicado: (2023)

Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?
por: Porfirio, Maria-Cristina, et al.
Publicado: (2017)

Adapting a parent training program to the COVID-19 crisis in a mental health care setting in France
por: Maurice, V., et al.
Publicado: (2022)

Cognitive Training for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials
por: Cortese, Samuele, et al.
Publicado: (2015)

Exploring the Link between ADHD and Obesity: A Focus on Temperament
por: Porfirio, Maria Cristina, et al.
Publicado: (2022)

A systematic review of the literature on ethical aspects of transitional care between child- and adult-orientated health services
por: Paul, Moli, et al.
Publicado: (2018)

Comment les enfants et adolescents avec le trouble déficit d’attention/hyperactivité (TDAH) vivent-ils le confinement durant la pandémie COVID-19 ?
por: Bobo, E., et al.
Publicado: (2020)

A Neurodevelopment Approach for a Transitional Model of Early Onset Schizophrenia
por: De Berardis, Domenico, et al.
Publicado: (2021)

Specific cortical and subcortical alterations for reactive and proactive aggression in children and adolescents with disruptive behavior
por: Naaijen, Jilly, et al.
Publicado: (2020)

Age-related brain deviations and aggression
por: Holz, Nathalie E., et al.
Publicado: (2023)

Early Interventions to Prevent Post-Traumatic Stress Disorder in Youth after Exposure to a Potentially Traumatic Event: A Scoping Review
por: Kerbage, Hala, et al.
Publicado: (2022)

European guidelines on managing adverse effects of medication for ADHD
por: Graham, J., et al.
Publicado: (2010)

Two cases of life‐threatening arrhythmia induced by risperidone: evaluation of risperidone and 9‐hydroxy‐risperidone concentrations
por: Ito, Asami, et al.
Publicado: (2017)

Efficacy of cognitive behavioral therapy on aggressive behavior in children with attention deficit hyperactivity disorder and emotion dysregulation: study protocol of a randomized controlled trial
por: Vacher, C., et al.
Publicado: (2022)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

RISPERIDONE IN SCHIZOPHRENIA
por: Kumar, P.N. Suresh
Publicado: (1999)

Interplay between genome-wide implicated genetic variants and environmental factors related to childhood antisocial behavior in the UK ALSPAC cohort
por: Ruisch, I. Hyun, et al.
Publicado: (2018)

Aggression subtypes relate to distinct resting state functional connectivity in children and adolescents with disruptive behavior
por: Werhahn, Julia E., et al.
Publicado: (2020)

Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD
por: Bioulac, Stéphanie, et al.
Publicado: (2019)

Mental Health of Children With Attention Deficit and Hyperactivity Disorder and Their Parents During the COVID-19 Lockdown: A National Cross-Sectional Study
por: Bobo, E., et al.
Publicado: (2022)

Parent training for the treatment of irritability in children and adolescents: a multisite randomized controlled, 3-parallel-group, evaluator-blinded, superiority trial
por: Fongaro, E., et al.
Publicado: (2022)

Non-violent resistance parental training versus treatment as usual for children and adolescents with severe tyrannical behavior: a randomized controlled trial
por: Fongaro, Erica, et al.
Publicado: (2023)

RISPERIDONE AUGMENTATION OF CLOZAPINE
por: Agarwal, Vivek
Publicado: (1999)

Galactorrhea Induced by Risperidone
por: Sakaguchi, Shota, et al.
Publicado: (2019)

Starting ADHD medications during the COVID-19 pandemic: recommendations from the European ADHD Guidelines Group
por: Cortese, Samuele, et al.
Publicado: (2020)

Audit on prolactin monitoring for patients on oral risperidone, intramuscular risperidone, and intramuscular paliperidone
por: Bader, Mohamed
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_91h6etufdjm0u9ss1pctsor0ja